Bharat Edition

Bharatstox

← All stocks

Gujarat Themis Biosyn Ltd.

NSE: GUJTHEM · Chemicals

Sector

Chemicals

Size band

Small cap

Market cap

2,873cr

P/E

60.1

ROE

33.8%

Dividend yield

0.3%

No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.

Measured against

Operating margin48.0%
peer 16.0%
Revenue growth22.2%
peer 23.5%
Gujarat Themis Biosyn Ltd.peer median

Peer set

Specialty Chemicals · 7 measured at Q1 FY27 · financials via Screener
CompanyOperating marginRevenue growth
Hexaware Technologies Ltd.16.0%17.9%
Gujarat Ambuja Exports Ltd.15.0%23.5%
Chemplast Sanmar Ltd.−10.0%2.3%
Gujarat Themis Biosyn Ltd.48.0%22.2%
Bhagiradha Chemicals & Industries Ltd.16.0%57.3%
NGL Fine-Chem Ltd.17.0%33.7%
Dhampur Bio Organics Ltd.1.7%8.3%
OCCL Ltd.28.0%78.9%

No guidance on record.

This section quotes what management told the market on the quarterly earnings call. We have not transcribed one for Gujarat Themis Biosyn Ltd..

No broadcast calls recorded.

We log calls made about a company on business television — Zee Business, CNBC Awaaz and NDTV Profit — as they are stated on air. Nothing is on record for Gujarat Themis Biosyn Ltd..

Shareholding

change across 4 filings
CategoryAug 26Jun 26Mar 26Dec 25Change
Promoters59.370.970.970.9−11.6
Foreign institutions4.91.81.82.0+2.9
Domestic institutions13.81.21.21.2+12.6
Retail & others22.026.226.226.0−4.0

As filed with the exchange for the periods ending Dec 25 to Aug 26.

Filings

latest 25 of 172
  • Certificate under SEBI (Depositories and Participants) Regulations, 201812 Oct 2026
    RoutineGeneralFiling PDF ↗
  • Credit Rating9 Oct 2026
    Medium impactCredit RatingFiling PDF ↗
  • Shareholders meeting1 Oct 2026
    RoutineGeneralFiling PDF ↗
  • Shareholders meeting30 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Shareholders meeting30 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Amendment to AOA/MOA30 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Shareholders meeting30 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Shareholders meeting30 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Trading Window23 Sept 2026
    Medium impactInsider TradingFiling PDF ↗
  • Kindly refer to the intimation of trading window closure.23 Sept 2026
    High impactInsider TradingFiling PDF ↗
  • Please refer to the Newspaper Publication of Corrigendum to the Notice of 45th Annual General Meeting.23 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Copy of Newspaper Publication23 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Shareholders meeting21 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Please refer to the attachment.21 Sept 2026
    RoutineGeneralFiling PDF ↗
  • General Updates18 Sept 2026
    Medium impactDividendFiling PDF ↗
  • Kindly refer to the attachment.18 Sept 2026
    RoutineGeneralFiling PDF ↗
  • General Updates18 Sept 2026
    High impactM&AFiling PDF ↗
  • Please refer to the attachment.18 Sept 2026
    RoutineGeneralFiling PDF ↗
  • General Updates16 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Please refer to the Disclosure under Reg 30 of LODR.16 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Outcome of Board Meeting10 Sept 2026
    RoutineBoard MeetingFiling PDF ↗
  • Please refer to the Outcome of the Board meeting held on 10.09.202610 Sept 2026
    RoutineBoard MeetingFiling PDF ↗
  • Please refer to the attachment8 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Shareholders meeting8 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/09/2026 ,inter alia, to consider and approve raising funds through ....7 Sept 2026
    RoutineBoard MeetingFiling PDF ↗

The 25 most recent of 172 filings we hold for GUJTHEM, back to January 2024. Every filing, by day.

Disclaimer

Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.

Bharat ke stocks, har subah.

One daily brief on what India's SEBI-registered research analysts are calling. No noise, no spam, unsubscribe whenever.